// company-profile
Lineage Cell Therapeutics, Inc.
LCTXExchangeNYSESectorBiological Products, (No Diagnostic Substances)Inc.CAFilings49Insiders13
// api This Lineage Cell Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
No insider transactions in the last 30 days.
No insider activity recorded for LCTX in the last 90 days.
Institutional Ownership
Top 13F-HR holders of Lineage Cell Therapeutics, Inc. as of 2026-03-31
Total reported AUM
$173.0M
QoQ change
+6.4%
Reporting period
2026-03-31
#1
BROADWOOD CAPITAL INC
CIK 1278387
$78.3M
49.6M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$13.1M
8.3M shares
#3
Defender Capital, LLC.
CIK 1766929
$10.6M
6.7M shares
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Culley Brian M | LCTX | Purchase | 15,000 | $1.63 | $24K |
| Mar 5, 2026 | Samuel George A. III | LCTX | Award | 900,000 | $0.00 | $0K |
| Mar 5, 2026 | Howe Jill Ann | LCTX | Award | 1,050,000 | $0.00 | $0K |
| Mar 5, 2026 | Culley Brian M | LCTX | Award | 3,250,000 | $0.00 | $0K |
| Feb 11, 2026 | Culley Brian M | LCTX | Option Exercise | 31,250 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.